Function of New vascular endothelial growth factor (EG-VEGF) in colon cancer.
| Project/Area Number |
20591587
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | University of Fukui |
|---|
Principal Investigator |
YAMAGUCHI Akio University of Fukui, 医学部附属病院, 教授 (10174608)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
GOI Takanori 福井大学, 医学部附属病院, 講師 (60225638)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 大腸癌 / 血管新生因子 / 浸潤 / 転移 / EG-VEGF |
|---|
| Research Abstract |
To improve the prognosis of cancer patients, it is essential to inhibit the capacity of cancer cells for hematogenous metastasis as well as their proliferative capacity. EG-VEGF factor enhances the angiogenesis and cell invasion in colon cancer. EG-VEGF antibody that we established, inhibibites the angiogenesis and cell inavasion in colon cancer. EG-VEGF molecule-targeted therapy has the potential for improving survival rates.
|
Report
(4 results)
Research Products
(9 results)
